Elucidating the effects of mTOR inhibitors from Malaysian natural products on tuberous sclerosis complex cell line
Mammalian target of rapamycin (mTOR) inhibitors are a highly recommended first-line therapy for tuberous sclerosis complex (TSC)-associated angiomyolipoma. Everolimus has been approved by the United States Food and Drug Administration (USFDA) for treatment of TSC-related angiomyolipoma that do no...
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2022
|
| Subjects: | |
| Online Access: | http://eprints.usm.my/53406/1/NINIE%20NADIA%20BINTI%20ZULKIPLI-FINAL%20THESIS%20P-UD001418%28R%29%20PWD_-24%20pages.pdf |